Editor's Choice
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology27 Jun 2023
Eli Lilly has announced its acquisition of DICE Therapeutics, a biopharmaceutical company focused on developing novel oral therapeutic candidates for... Continue Reading
|
Rimidi Enhances Integration with Dexcom, Adds Glycemic Risk Index to Diabetes Platform27 Jun 2023
Rimidi, a clinical management platform, has enhanced its diabetes management platform by integrating Glycemic Risk Index (GRI) and continuous glucose... Continue Reading
|
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal27 Jun 2023
Several states, including Illinois, California, and New York, have joined the Federal Trade Commission (FTC) in a lawsuit to block... Continue Reading
|
Medtronic, Allurion Launches AI-Powered Weight Loss Piloty27 Jun 2023
Allurion, a company focused on ending obesity, has partnered with Medtronic to expand access to its AI-powered weight loss program... Continue Reading
|
Key Takeaways from PegaWorld iNspire 2023.27 Jun 2023
The recent PegaWorld iNspire conference highlighted the pressing need for healthcare organizations to improve information handling and reduce paperwork. Attendees... Continue Reading
|
Outbound AI Raises $16M for AI-Powered Virtual Agents27 Jun 2023
Seattle-based conversational AI platform for healthcare, Outbound AI, has raised $16M in seed funding co-led by Madrona Venture Group and... Continue Reading
|
HandSport Surgery Institute Launches Virtual Practice in Metaverse.19 Jun 2023
HandSport Surgery Institute (HSSI) has launched a virtual practice in Decentraland, a blockchain-based metaverse platform. The virtual practice features a... Continue Reading
|
U.S. Digital Therapeutics Market to Reach $21.46B by 203019 Jun 2023
The U.S. digital therapeutics market is projected to reach $21.46 billion by 2030, growing at a CAGR of 33.8% from... Continue Reading
|
Value-Based Care Versus Fee-for-Service: Understanding the Key Differences in Healthcare Models19 Jun 2023
The article discusses the differences between value-based care and fee-for-service models in behavioral healthcare. It highlights how technology and outcome... Continue Reading
|
Cala Launches FDA-Cleared Wearable Device for Tremor Relief19 Jun 2023
Cala has launched the Cala kIQ System, an FDA-cleared wearable device for providing on-demand therapy to relieve action hand tremors... Continue Reading
|